We aim to develop a simple prognostic tool for rheumatic heart disease. In the first phase of the project we aim to identify a set of
peptides that induce a pro-inflammatory cytokine response from T cells isolated from rheumatic heart disease patients in Salvador, Brazil. The development of a prognostic tool which is inexpensive, simple and portable will help neglected populations get the appropriate treatment and care necessary to prevent severe outcomes from this preventable and neglected disease.
Better Journey
Better Journey provides a platform for organizations to more effectively engage with refugee communities at scale and track key milestones along a refugee’s path. Through